Nyssen, O. P. Et Al. 2022. Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg). Clinical Gastroenterology and Hepatology , vol.20, no.10 , 2243-2257.

Nyssen, O. P., Vaira, D., Pérez Aísa, Á., Rodrigo, L., Castro-Fernandez, M., Jonaitis, L., ... Tepes, B.(2022). Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg). Clinical Gastroenterology and Hepatology , vol.20, no.10, 2243-2257.

Nyssen, Olga Et Al. "Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)," Clinical Gastroenterology and Hepatology , vol.20, no.10, 2243-2257, 2022

Nyssen, Olga P. Et Al. "Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)." Clinical Gastroenterology and Hepatology , vol.20, no.10, pp.2243-2257, 2022

Nyssen, O. P. Et Al. (2022) . "Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)." Clinical Gastroenterology and Hepatology , vol.20, no.10, pp.2243-2257.

@article{article, author={Olga P. Nyssen Et Al. }, title={Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)}, journal={Clinical Gastroenterology and Hepatology}, year=2022, pages={2243-2257} }